NCT04665323View on ClinicalTrials.gov

An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.

CompletedOBSERVATIONAL
Enrollment

411

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Fibrodysplasia Ossificans Progressiva
Trial Locations (1)

02142

Ipsen Central Contact, Cambridge

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY